STOCK TITAN

So-Young International Inc. American Depository Shares - SY STOCK NEWS

Welcome to our dedicated page for So-Young International American Depository Shares news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young International American Depository Shares stock.

So-Young International Inc. (symbol: SY) operates a leading online platform for medical aesthetics and elective healthcare services. Established in China, the company focuses on providing users with reliable information about medical aesthetic procedures. Through its platform, users can discover content, share personal experiences, and reserve treatment services from vetted medical aesthetic providers. This service is available not only in China but also internationally.

So-Young's business model includes four key components: distribution of professional content via social media and targeted media platforms, a vibrant social community rich in user-generated content, online reservation services for medical aesthetic treatments, and the research, development, and sales of medical beauty equipment. The company generates revenue through information service fees and reservation fees from its network of approximately 6,100 medical aesthetic service providers.

In addition to aesthetical treatments, So-Young facilitates user reservations for a broad range of medical services, including dermatology, dentistry, ophthalmology, gynecology, HPV vaccinations, and postnatal care.

Recent achievements include several strategic developments and new partnerships. For instance, in November 2023, So-Young reported strong financial results with a 19.2% increase in total revenues year-over-year to RMB385.3 million. In December 2023, the company announced a significant partnership with Healtech to develop regenerative medical aesthetic products, marking a major step in expanding their supply chain business.

Additionally, the leadership team has undergone recent changes to bolster expertise and drive growth. As of October 2023, the board appointed Ms. Nan Shen, a seasoned financial expert, as an independent director. This appointment aligns with So-Young's commitment to reinforcing internal growth and maintaining high standards of governance.

Financially, So-Young has demonstrated resilience despite macroeconomic challenges, achieving a net income of RMB18.3 million in the third quarter of 2023. The company maintains a strong cash position with RMB1,405.4 million in cash, cash equivalents, restricted cash, and short-term investments as of September 30, 2023.

Leveraging its strong brand image, extensive audience reach, and rich data insights, So-Young is well-positioned to expand both within the medical aesthetic industry and the broader consumption healthcare market. For investors, So-Young continues to stand out as a promising player in the fast-growing medical aesthetics sector.

Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) announced the repurchase of approximately 13.3 million ADSs, representing 10.3 million Class A ordinary shares, for US$54.5 million. The company plans to cancel all repurchased shares, reflecting a strategic move in its capital structure.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
buyback
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) announced the approval of 2,923,077 restricted share units for Mr. Xing Jin, the chairman and CEO, to recognize his contribution and incentivize him to lead the company to greater business results. Mr. Jin has agreed not to sell more than one-third of the total Class A ordinary shares to be issued upon the vesting of the Restricted Share Units in each year ending December 31, 2024, 2025 and 2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.42%
Tags
none
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) has announced a strategic partnership with Healtech to develop regenerative medical aesthetic products and expand its supply chain business. The partnership aims to leverage So-Young's consumer reach and Healtech's R&D capabilities to bring new products to the market quickly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.22%
Tags
partnership
Rhea-AI Summary
So-Young International Inc. (Nasdaq: SY) announced unaudited financial results for Q3 2023, showing total revenues of RMB385.3 million, a 19.2% increase from the same period in 2022. Net income attributable to So-Young was RMB18.3 million, compared to RMB2.3 million in Q3 2022. The company's average mobile MAUs were 3.1 million, and the number of medical service providers subscribing to information services on So-Young's platform decreased to 1,397 from 1,704 in Q3 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.4%
Tags
-
Rhea-AI Summary
So-Young International Inc. (Nasdaq: SY) announces that its subsidiary, Wuhan Miracle, has submitted application documents for a potential IPO and listing on the Beijing Stock Exchange. Wuhan Miracle plans to issue up to 20,000,000 shares, accounting for approximately 25% of its total share capital after the IPO. So-Young currently owns approximately 87.60% of Wuhan Miracle's shares.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) announces the release of its financial results for the third quarter of 2023 on November 20, 2023, along with an earnings conference call. The company is the largest social community in China for the medical aesthetics industry. Dial-in and webcast details are provided for the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.9%
Tags
conferences earnings
News
Rhea-AI Summary
So-Young International announces resignations and new appointments of directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
none
-
Rhea-AI Summary
So-Young International Inc. announces Q2 2023 financial results with total revenues of RMB412.1 million, a 33.3% increase from the same period in 2022. Non-GAAP net income attributable to So-Young was RMB15.5 million, compared to a loss of RMB22.7 million in Q2 2022. Average mobile MAUs decreased to 3.0 million from 3.5 million in Q2 2022. Number of medical service providers subscribing to information services decreased to 1,659 from 2,622 in Q2 2022. Positive growth momentum and profitability improvement observed. Q3 2023 total revenues expected to increase by 17.5% to 23.7% from the same period in 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.26%
Tags
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) will report its financial results for Q2 2023 on August 21, 2023. The company is the largest social community in China for the medical aesthetics industry. An earnings conference call will be held on the same day at 7:30 AM U.S. Eastern Time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.9%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.65%
Tags

FAQ

What is the current stock price of So-Young International American Depository Shares (SY)?

The current stock price of So-Young International American Depository Shares (SY) is $0.77 as of December 20, 2024.

What is the market cap of So-Young International American Depository Shares (SY)?

The market cap of So-Young International American Depository Shares (SY) is approximately 78.2M.

What does So-Young International Inc. do?

So-Young International Inc. operates an online platform for discovering, evaluating, and reserving medical aesthetic services. They provide information, user reviews, and reservation services for various medical treatments.

Where are So-Young's services available?

So-Young's services are available both in China and internationally. Users can access the platform to learn about and reserve medical aesthetic procedures globally.

What are So-Young’s main revenue sources?

So-Young generates revenue primarily from information service fees and reservation service fees charged to medical aesthetic service providers.

Who are So-Young's partners?

So-Young partners with a wide network of approximately 6,100 medical aesthetic service providers. Recently, they entered a strategic partnership with Healtech for developing regenerative medical aesthetic products.

What recent financial achievements has So-Young reported?

In the third quarter of 2023, So-Young reported a 19.2% increase in total revenues year-over-year and a net income of RMB18.3 million. They maintain a strong cash position with RMB1,405.4 million in cash and equivalents.

What services does So-Young offer beyond medical aesthetics?

Besides medical aesthetics, So-Young offers reservation services for dermatology, dentistry, ophthalmology, gynecology, HPV vaccinations, and postnatal care.

What recent leadership changes have occurred at So-Young?

In October 2023, So-Young appointed Ms. Nan Shen as an independent director, enhancing the board’s financial and operational expertise.

What strategic developments has So-Young undertaken recently?

In December 2023, So-Young entered a partnership with Healtech to develop regenerative medical aesthetic products, expanding their supply chain business.

How does So-Young ensure the quality of its service providers?

So-Young curates its medical aesthetic service providers carefully, ensuring they are thoroughly vetted to provide high-quality and trustworthy services to users.

What is the future outlook for So-Young?

So-Young aims to expand along the medical aesthetic industry value chain and the fast-growing consumption healthcare market, leveraging its strong brand, extensive reach, and data insights.

So-Young International Inc. American Depository Shares

Nasdaq:SY

SY Rankings

SY Stock Data

78.25M
72.18M
16.02%
24.55%
0.02%
Health Information Services
Healthcare
Link
United States of America
Beijing